Clinical Trials in Denver

Showing 4281-4300 of 18,161 trials

A Community-based Assessment of Skin Care, Allergies, and Eczema

NCT03409367

Atopic dermatitis (AD) affects over 9 million children in the U.S. and often heralds the development of asthma, food allergy, skin infections and neurodevelopmental disorders. Recent advances identify skin barrier dysfunction to be the key initiator of AD and possibly allergic sensitization. Our central hypothesis is that daily emollient use from birth can prevent the development of AD in a community setting and into newborns unselected for risk. The results of a community-based clinical trial utilizing a pragmatic trial design will be immediately applicable to the population at large and will establish a new standard of care for all newborns.

Atopic DermatitisAtopic DisordersEczema+1 more

Oregon Health and Science University1,260 participantsStarted Jul 2018

Denver, Colorado, United States • Durham, North Carolina, United States • Portland, Oregon, United States +1 more locations

COMPLETEDPhase 25.0 miles

A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Participants With Chronic Rhinosinusitis With Nasal Polyps

NCT06164704

The primary purpose of this study is to assess the effect of verekitug (UPB-101) on the endoscopically determined size and extend of nasal polyps in participants with chronic rhinosinusitis with nasal polyps (CRSwNP) and to assess the safety and tolerability of verekitug (UPB-101) compared to placebo.

Chronic Rhinosinusitis With Nasal Polyps

Upstream Bio Inc.81 participantsStarted Dec 2023

Los Angeles, California, United States • Newport Beach, California, United States • Roseville, California, United States +38 more locations

A Community-based Assessment of Skin Care, Allergies, and Eczema

A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Participants With Chronic Rhinosinusitis With Nasal Polyps

Find Trials by Condition in Denver

INSPIRE Trial for Abdominal Infections

Veliparib With or Without Carboplatin in Treating Patients With Stage III or IV Breast Cancer

A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors

Mepolizumab as Add-on Treatment IN Participants With COPD Characterized by Frequent Exacerbations and Eosinophil Level

Study of EYP-1901 in Patients With Nonproliferative Diabetic Retinopathy (NPDR)

Blinatumomab and Nivolumab With or Without Ipilimumab in Treating Patients With Poor-Risk Relapsed or Refractory CD19+ Precursor B-Lymphoblastic Leukemia

A Study to Learn About Flu and COVID-19 Vaccine Responses in Healthy People

ALPN-101 (Acazicolcept) in Systemic Lupus Erythematosus

Efficacy and Safety of Pembrolizumab (MK-3475) With Lenvatinib (E7080/MK-7902) vs. Docetaxel in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) and Progressive Disease (PD) After Platinum Doublet Chemotherapy and Immunotherapy (MK-7902-008/E7080-G000-316/LEAP-008)

Machine Learning Prediction of Possible Central Line Associated Blood Stream Infections and Rate of Reduction

Active-control Randomized Trial Comparing 4-factor Prothrombin Complex Concentrate With Frozen Plasma in Cardiac Surgery

Minimal Residual Disease Testing for the Early Detection of Cancer Recurrence in Resectable Stage II-IV Colorectal Cancer Patients

Lupus Landmark Study: A Prospective Registry and Biorepository

Zibotentan and Dapagliflozin Combination, EvAluated in Liver Cirrhosis (ZEAL Study)

Actis Total Hip System 2 Year Follow-up

Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With Stage II-IV HIV-Associated Hodgkin Lymphoma

Severe Asthma Research Program

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors